SFS
TEVA icon

Sowell Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Sowell Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Sell
90,986
-1,680
-2% -$56K 0.1% 212
2026
Q1 		$2.79M Sell
92,666
-664
-0.7% -$21.4K 0.1% 210
2025
Q4 		$2.91M Buy
93,330
+48,366
+108% +$1.19M 0.11% 196
2025
Q3 		$908K Sell
44,964
-2,544
-5% -$44.7K 0.03% 453
2025
Q2 		$796K Sell
47,508
-2,405
-5% -$38.8K 0.03% 475
2025
Q1 		$767K Buy
49,913
+313
+0.6% +$5.59K 0.03% 471
2024
Q4 		$1.09M Buy
49,600
+9,291
+23% +$169K 0.06% 301
2024
Q3 		$726K Sell
40,309
-4,718
-10% -$82.6K 0.03% 399
2024
Q2 		$732K Sell
45,027
-2,780
-6% -$42.8K 0.04% 382
2024
Q1 		$675K Hold
47,807
– – 0.03% 410
2023
Q4 		$499K Sell
47,807
-200
-0.4% -$1.87K 0.03% 428
2023
Q3 		$490K Buy
48,007
+200
+0.4% +$1.86K 0.03% 397
2023
Q2 		$360K Buy
47,807
+410
+0.9% +$3.33K 0.02% 494
2023
Q1 		$419K Sell
47,397
-440
-0.9% -$4.35K 0.03% 480
2022
Q4 		$436K Buy
47,837
+6,350
+15% +$55.4K 0.03% 446
2022
Q3 		$335K Hold
41,487
– – 0.03% 358
2022
Q2 		$312K Buy
+41,487
New +$361K 0.03% 250
2022
Q1 		– Sell
-36,623
Closed -$293K – 486
2021
Q4 		$293K Buy
36,623
+2,451
+7% +$22.1K 0.02% 485
2021
Q3 		$333K Hold
34,172
– – 0.02% 441
2021
Q2 		$338K Buy
34,172
+504
+1% +$5.33K 0.02% 462
2021
Q1 		$346K Buy
33,668
+32,066
+2,002% +$368K 0.01% 780
2020
Q4 		$15K Sell
1,602
-737
-32% -$7.06K ﹤0.01% 1865
2020
Q3 		$21K Buy
2,339
+264
+13% +$2.79K ﹤0.01% 1549
2020
Q2 		$26K Sell
2,075
-1,440
-41% -$16.3K ﹤0.01% 1382
2020
Q1 		$32K Sell
3,515
-2,750
-44% -$28.2K ﹤0.01% 1221
2019
Q4 		$61K Buy
6,265
+1,810
+41% +$16.2K ﹤0.01% 1085
2019
Q3 		$31K Buy
+4,455
New +$34.1K ﹤0.01% 1139

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sowell Financial Services's TEVA Position: Q2 2026 in Review

Sowell Financial Services reduced its Teva Pharmaceuticals (TEVA) stake by 1.8% in Q2 2026, selling an estimated $56K and leaving 90,986 shares worth $3.08M. The position accounts for 0.1% of the portfolio, ranked #212.

Sowell Financial Services first reported a position in TEVA in Q3 2019 and has held it in 27 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sowell Financial Services held 90,986 shares of Teva Pharmaceuticals worth $3.08M as of Q2 2026.
  • Sowell Financial Services sold 1,680 Teva Pharmaceuticals shares in Q2 2026, an estimated $56K.
  • Teva Pharmaceuticals made up 0.1% of Sowell Financial Services's portfolio in Q2 2026, its #212 holding.
  • Sowell Financial Services first reported a position in Teva Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.